Gilead Sciences (GILD) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Gilead Sciences (GILD) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 20, 2024 (05:18)

Sector: Healthcare

The share price of Gilead Sciences, Inc. (GILD) now

Latest session on the 19th of July for
Gilead Sciences, Inc. is negative
Trading Volume: 5567576
Open: 73.51 /  High: 73.74 /  Low: 71.96
What analysts predict: $81.58
52-week High/Low: $85.93 / $61.32

50/200 Day Moving Average: $66.82 / $73.45

This figure corresponds to the Average Price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the support level today.

For Gilead Sciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Gilead Sciences share be worth in 2024 - 2028?

When should I take profit in Gilead Sciences stock? When should I record a loss on Gilead Sciences stock? What are analysts' forecasts for Gilead Sciences stock? What is the future of Gilead Sciences stock? We forecast Gilead Sciences stock performance using neural networks based on historical data on Gilead Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Gilead Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Gilead Sciences shares. This happens once a day.


Historical and forecast chart of Gilead Sciences stock

The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Gilead Sciences stock price can be found in the table below.

Long-term forecasts by years.

Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.

Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.

Official site of the company

Gilead Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 22 72.62 72.35 72.91 0.78
Jul 23 72.52 71.97 72.90 1.29
Jul 24 72.78 72.24 73.30 1.47
Jul 25 72.87 72.46 73.05 0.81
Jul 26 73.42 73.07 73.81 1.00
Jul 27 73.41 72.97 73.95 1.34
Jul 28 73.25 72.81 73.53 0.99
Jul 29 73.40 73.06 73.64 0.79
Jul 30 73.30 72.76 73.54 1.07
Jul 31 73.17 72.78 73.43 0.89
Aug 01 73.26 72.79 73.69 1.24
Aug 02 73.18 72.91 73.64 0.99
Aug 03 73.34 73.05 73.65 0.82
Aug 04 73.28 72.79 73.77 1.35
Aug 05 73.48 72.95 73.94 1.35
Aug 06 73.38 72.81 73.96 1.57
Aug 07 73.02 72.54 73.47 1.29
Aug 08 72.79 72.55 73.19 0.89
Aug 09 72.06 71.73 72.38 0.89
Aug 10 72.14 71.71 72.57 1.20
Aug 11 72.01 71.63 72.31 0.95
Aug 12 72.32 71.87 72.48 0.85
Aug 13 72.25 71.92 72.66 1.02
Aug 14 72.77 72.35 73.30 1.31
Aug 15 72.90 72.36 73.17 1.12
Aug 16 72.88 72.71 73.11 0.54
Aug 17 72.20 71.67 72.78 1.55
Aug 18 72.15 71.81 72.41 0.84
Aug 19 72.39 72.24 72.68 0.61
Aug 20 72.40 72.22 72.60 0.52

Gilead Sciences Daily Price Targets


Gilead Sciences Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $72.62.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.777%.
Pessimistic target level: 72.35
Optimistic target level: 72.91

Gilead Sciences Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $72.52.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 1.273%.
Pessimistic target level: 71.97
Optimistic target level: 72.90

Gilead Sciences Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $72.78.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.450%.
Pessimistic target level: 72.24
Optimistic target level: 73.30

Gilead Sciences Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $72.87.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.808%.
Pessimistic target level: 72.46
Optimistic target level: 73.05

Gilead Sciences Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $73.42.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.995%.
Pessimistic target level: 73.07
Optimistic target level: 73.81

Gilead Sciences Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $73.41.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 1.320%.
Pessimistic target level: 72.97
Optimistic target level: 73.95

GILD (GILD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 75.05 72.20 76.70 5.87
Sep. 74.27 71.37 75.83 5.88
Oct. 75.60 74.43 76.74 3.00
Nov. 77.38 74.48 80.24 7.18
Dec. 73.74 71.79 75.92 5.44

Gilead Sciences forecast for this year


Gilead Sciences Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $75.0537. Pessimistic: $72.20. Optimistic: $76.70


Gilead Sciences Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $74.2656. Pessimistic: $71.37. Optimistic: $75.83


Gilead Sciences Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $75.6024. Pessimistic: $74.43. Optimistic: $76.74


Gilead Sciences Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $77.3791. Pessimistic: $74.48. Optimistic: $80.24


Gilead Sciences Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $73.7423. Pessimistic: $71.79. Optimistic: $75.92



Gilead Sciences (GILD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 72.08 69.88 74.03 5.60
Feb 73.52 71.98 74.63 3.55
Mar 73.75 72.68 76.29 4.74
Apr 72.64 70.86 73.87 4.08
May 71.77 70.58 74.35 5.07
Jun 71.37 68.91 73.19 5.85
Jul 72.34 69.59 73.93 5.87
Aug 73.24 72.51 75.29 3.70
Sep 75.91 73.22 77.74 5.81
Oct 74.24 71.94 75.62 4.86
Nov 76.06 73.32 77.58 5.49
Dec 75.00 74.17 77.70 4.54

Gilead Sciences (GILD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 75.71 74.20 76.58 3.11
Feb 77.68 75.93 78.96 3.84
Mar 76.40 73.53 79.41 7.41
Apr 76.09 73.05 77.08 5.23
May 76.24 73.23 77.65 5.69
Jun 73.31 72.58 74.48 2.56
Jul 75.47 73.13 77.43 5.56
Aug 75.06 73.52 76.11 3.40
Sep 73.25 72.30 76.18 5.10
Oct 76.15 73.75 78.93 6.56
Nov 77.25 75.94 79.49 4.47
Dec 78.91 75.84 80.45 5.74

Gilead Sciences (GILD) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 80.73 78.47 82.83 5.26
Feb 80.57 77.91 82.58 5.66
Mar 83.10 80.49 84.27 4.49
Apr 83.02 80.07 85.59 6.45
May 85.51 83.20 86.84 4.19
Jun 88.12 86.62 89.62 3.34
Jul 86.93 85.67 89.19 3.95
Aug 86.15 83.91 87.48 4.09
Sep 89.59 87.31 93.09 6.21
Oct 88.43 86.04 91.61 6.08
Nov 87.28 85.05 89.46 4.93
Dec 83.48 82.23 84.48 2.67

Gilead Sciences (GILD) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 81.44 79.52 83.92 5.24
Feb 81.97 78.73 82.87 5.00
Mar 81.27 78.22 82.16 4.80
Apr 80.82 79.17 83.53 5.23
May 81.55 79.19 84.49 6.27
Jun 81.59 80.12 83.63 4.20
Jul 81.55 80.74 84.24 4.16
Aug 82.45 81.54 83.93 2.85
Sep 82.12 80.76 84.62 4.56
Oct 81.30 79.26 82.48 3.89
Nov 81.42 80.32 82.72 2.90
Dec 80.73 78.06 82.70 5.61

Gilead Sciences information and performance

Gilead Sciences Address

333 LAKESIDE DR, FOSTER CITY, CA, US

Market Capitalization: 91 320 812 000 $

Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.

EBITDA: 12 665 000 000 $

EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: 203.61

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.421

Price/earnings to growth

DPS: 3.02

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.042

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.36

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.131
Quarterly Revenue Growth YOY: 0.053
Trailing PE: 203.61

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 9.64

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.784

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.78

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1245850000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Gilead Sciences (GILD) stock dividend

Gilead Sciences last paid dividends on 06/14/2024. The next scheduled payment will be on 06/27/2024. The amount of dividends is $3.02 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.